Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCIO-469 in Active Rheumatoid Arthritis
NCT00089921Phase 2Completed
- Sponsor
- Scios Inc.
- Start
- Jul 2004
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of talmapimod in rheumatoid arthritis (RA), sponsored by Scios Inc.. Started Jul 2004; status: completed.
02
Drugs
talmapimod
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00089921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00089921.